Risk of bacterial meningitis in children with cochlear implants.
BACKGROUND
In June 2002, the Food and Drug Administration received reports of bacterial meningitis in patients with cochlear implants for treatment of hearing loss. Implants that included a positioner (a wedge inserted next to the implanted electrode to facilitate transmission of the electrical signal by pushing the electrode against the medial wall of the cochlea) were voluntarily recalled in the United States in July 2002.


METHODS
We identified patients with meningitis and conducted a cohort study and a nested case-control investigation involving 4264 children who had received cochlear implants in the United States between January 1, 1997, and August 6, 2002, and who were less than six years of age when they received the implants. We calculated the incidence of meningitis in the cohort and assessed risk factors for meningitis among patients and among 199 controls, using data from interviews with parents and abstracted from medical records.


RESULTS
We identified 26 children with bacterial meningitis. The incidence of meningitis caused by Streptococcus pneumoniae was 138.2 cases per 100,000 person-years--more than 30 times the incidence in a cohort of the same age in the general U.S. population. Postimplantation bacterial meningitis was strongly associated with the use of an implant with a positioner (odds ratio, 4.5 [95 percent confidence interval, 1.3 to 17.9], with adjustment for medical, surgical, and environmental factors) and with the joint presence of radiographic evidence of a malformation of the inner ear and a cerebrospinal fluid leak (adjusted odds ratio, 9.3 [95 percent confidence interval, 1.2 to 94.5]). The incidence of meningitis among patients who had received an implant with a positioner remained higher than the incidence among those whose implants did not have a positioner for the duration of follow-up (24 months from the time of implantation).


CONCLUSIONS
Parents and health care providers should ensure that all children who receive cochlear implants are appropriately vaccinated and are then monitored and treated promptly for any bacterial infections after receiving the implant.
Reefhuis
Jennita
J
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Honein
Margaret A
MA
Whitney
Cynthia G
CG
Chamany
Shadi
S
Mann
Eric A
EA
Biernath
Krista R
KR
Broder
Karen
K
Manning
Susan
S
Avashia
Swati
S
Victor
Marcia
M
Costa
Pamela
P
Devine
Owen
O
Graham
Ann
A
Boyle
Coleen
C
D001428:Bacterial Vaccines; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D003054:Cochlear Implants / Q000009:adverse effects*; D015331:Cohort Studies; D007758:Ear, Inner / Q000002:abnormalities; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D008297:Male; D016920:Meningitis, Bacterial / Q000453:epidemiology / Q000209:etiology*; D008583:Meningitis, Haemophilus / Q000209:etiology; D008586:Meningitis, Pneumococcal / Q000453:epidemiology / Q000209:etiology; D011474:Prosthesis Design; D012307:Risk Factors; D013353:Subdural Effusion / Q000150:complications; D014481:United States / Q000453:epidemiology
D001428:Bacterial Vaccines